genetic familial mutations
498 articles
Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer
This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.
Could There Be a Cure in Vitamin C?
Vitamin C has been found to kill cancer cells that carry the KRAS mutation. This mutation is common in pancreatic and colorectal cancers.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
Solving the Mystery of Cachexia
Researchers are looking for ways to combat cachexia, the metabolic syndrome that causes weight and muscle loss in people with cancer and other diseases.
The First Line of Defense against Pancreatic Cancer
Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.